Invasive Aspergillosis Recruiting Phase 3 Trials for Olorofim (DB15245)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031838 (Invasive Aspergillosis) | Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05101187 | Olorofim Aspergillus Infection Study | Treatment |